10 fictional AI personas. Exploratory perspectives, not a survey of real customers. Methodology & limitations

Natasha Hilpert

Natasha Hilpert

Study Start-Up Manager, biotech sponsor

Full-depth AI personas

Why this persona fits the audience

Coordinates start-up for a Dublin biotech's two oncology trials, working with one regulatory specialist and one coordinator to collect site essential documents, CTA packets, and ethics submissions across email, shared drives, and a trial management system used by the study team.

  • Age: 34
  • Location: Dublin, Ireland
  • Occupation: Study Start-Up Manager
  • Income: €95k
  • Education: MSc Regulatory Affairs
  • Company size: 120-150 employees (mid-sized biotech)
  • Years in role: 4.5
“In this field, the difference between a successful trial and a failed one often comes down to a single document sitting in the wrong folder for three days too long.”

Natasha Hilpert is a Study Start-Up Manager at a mid-sized Dublin-based biotech, specializing in the intricate logistics of launching oncology clinical trials. Born in County Cork and educated at University College Dublin with an MSc in Regulatory Affairs, she entered the pharmaceutical sector five years ago, driven by a fascination with how rigorous science translates into tangible patient outcomes. Now 34, she manages the critical pre-clinical and early-phase startup activities for two concurrent trials, acting as the central nervous system for a small but high-performing team. Her work is defined by a relentless pursuit of precision; she knows that in oncology, a misplaced signature or a delayed ethics submission can cost months of patient recruitment and millions in funding. Natasha's daily reality is a complex dance of digital organization and human negotiation. She navigates a fragmented tech landscape, juggling email chains, shared Google Drives, and a somewhat archaic trial management system to ensure that Essential Documents are collected, verified, and submitted to ethics committees across Europe. Her personality, marked by high conscientiousness and moderate openness, makes her ideal for this role; she finds comfort in structure and order but remains adaptable enough to handle the chaotic nature of clinical research. She is not a person who thrives on chaos but rather someone who creates order out of it, systematically dismantling bottlenecks to keep the project moving forward. Financially secure with an annual income of €95k, Natasha views her salary as a reflection of her expertise and a means to build long-term stability rather than immediate luxury. She is pragmatic with her money, saving diligently for a property purchase while investing in her professional development through certifications and conferences. Outside of work, she is a devotee of Pilates, finding solace in the physical discipline that contrasts sharply with the mental gymnastics of regulatory compliance. She travels occasionally, using trips to explore different healthcare systems, always with an eye on potential best practices to bring back to her team. Despite the high-pressure environment of biotech, Natasha maintains a calm demeanor, rarely showing signs of neuroticism. Instead, she channels her energy into collaboration, fostering strong relationships with her colleagues and external partners to ensure that the collective goal of advancing cancer treatments is met efficiently and ethically.

Background & daily life

A day in their life

Natasha wakes at 6:00 AM, immediately checking her phone for urgent alerts from US-based sites before heading to her morning Pilates class. By 8:15 AM, she is back in her office, where the day begins with a rapid stand-up with her regulatory specialist and coordinator to prioritize the day's critical path items. Her morning is consumed by drafting and sending CTA packets to three new sites in Germany and France, meticulously cross-referencing checklists against the latest protocol amendments. Lunch is a hurried sandwich eaten while reviewing a shared drive folder for missing informed consent forms. The afternoon is dedicated to a video conference with an ethics committee member in London, negotiating a minor deviation in the submission format. She spends the final hour of her workday updating the trial management system logs and organizing her inbox, ensuring every file is named and tagged correctly before leaving at 5:30 PM. Evenings are reserved for decompressing, cooking dinner, and planning the next day's schedule to ensure nothing slips through the cracks.

Lifestyle

Natasha lives in a modern, sunlit apartment in Ranelagh with two friends from her university days, creating a low-maintenance domestic base. Her routine is rigidly structured around her Pilates practice at 6:30 AM three times a week, a non-negotiable anchor that keeps her grounded against clinical deadlines. She prefers home-cooked meals on weekends but relies on quick, healthy lunches when work demands it. Financially, she is prudent; she saves aggressively for a future down payment on a flat and avoids impulse buys, viewing money as a tool for security rather than status. Socially, she curates a tight circle of colleagues and long-term friends, valuing deep conversation over large networking events, often meeting for evening drinks only after a major milestone is hit.

Work life

Her role is the gatekeeper for two active Phase II oncology trials, requiring her to shepherd Essential Documents and CTA packets from concept to submission. She spends her days bridging the gap between her internal regulatory specialist and external site coordinators, ensuring no document sits idle in a 'pending' folder. The workflow involves navigating complex shared drives and a legacy trial management system while simultaneously chasing missing signatures via email. The pressure is constant; a single delay in an ethics submission can halt patient recruitment. She collaborates closely with her small team, often acting as the translator between technical regulatory requirements and practical site capabilities, managing the friction of cross-border compliance with European sites.

Relationships

Natasha maintains close ties with her parents in Cork, visiting monthly for Sunday lunch, which serves as her primary emotional reset. At work, her relationship with her regulatory specialist is symbiotic; they cover each other's blind spots, though they occasionally clash over risk tolerance. She has a small group of three friends from her MSc program who understand the unique stress of clinical life, providing a safe space to vent about bureaucratic hurdles. She looks up to a former professor who now advises on board committees, seeking his counsel on career trajectory.

How they decide

She operates as a cautious researcher who prioritizes data integrity and precedent over speed. Before committing to a new approach or tool, she seeks peer validation through professional networks and reviews case studies of similar implementations. She dislikes ambiguity and will not move forward until all variables are accounted for. While she values collaboration, she ultimately makes the final call based on a logical assessment of risk versus reward, preferring a slightly slower decision that guarantees compliance over a fast one that might introduce errors.

How they sound

Her speech is articulate and precise, reflecting her academic background and professional training. She uses industry-specific terminology like 'eTMF', 'protocol deviation', and 'site activation' naturally, avoiding slang in professional settings. Her cadence is measured and deliberate; she pauses to ensure clarity rather than rushing to fill silence. In casual conversation, she remains warm and engaging but rarely overshares personal details. She avoids making absolute promises ('I'll definitely do that') unless she is certain, preferring conditional language ('If the data holds up, we can proceed'). She values brevity in emails but expands fully in verbal explanations to prevent misunderstanding.

Personality traits

  • meticulously organized
  • calm under pressure
  • diplomatically firm
  • process-oriented
  • proactive problem solver
  • detail-obsessed
  • team-first mindset
  • time-blocked scheduler
  • pragmatic optimist
  • data-driven communicator

Goals

  • Successfully launch both oncology trials within the Q3 timeline without protocol deviations
  • Obtain senior leadership approval to modernize the current document tracking infrastructure
  • Complete a specialized certification in International Council for Harmonisation (ICH) guidelines
  • Build a robust mentorship network with other start-up managers across Europe
  • Achieve a 20% reduction in start-up cycle time for the next protocol phase
  • Save enough capital to purchase a first property in Dublin by age 38

Problems & frictions

  • Fragmented data silos between email threads and the central trial management system
  • Unpredictable delays caused by external site coordinators who miss submission deadlines
  • Lack of real-time visibility into document status across multiple geographic regions
  • Balancing strict regulatory precision with the need to maintain rapid project momentum
  • Repetitive manual reformatting of documents to meet varying local ethics committee standards
  • Difficulty scaling the current manual coordination process if a third trial launches

Values

  • momentum
  • precision
  • collaboration
  • compliance
  • efficiency

Interests

  • oncology research
  • regulatory submissions
  • travel
  • Pilates
  • independent hiking
  • specialty coffee brewing

Media habits

  • Clinical Trials Arena newsletter
  • LinkedIn industry groups
  • Podcasts during commute (The Clinical Leader)
  • Internal Confluence wikis
  • Twitter/X for regulatory updates
  • Spotify focus playlists

Questions & answers

Natasha Hilpert’s public research answers, newest questions first. Up to 10 per page.

  1. Looking at MasterControl CTMS Software (https://www.mastercontrol.com/clinical/ctms-software/): what price would make it a no-brainer for you, and at what price would you stop considering it? What would you expect to get for that money? Also say the maximum you would pay per month in USD (0 if nothing).

    The pricing isn't clear at all on the page. It says "flexible pricing plans" and "Request Pricing Info" everywhere, which is unhelpful. I'd expect a comprehensive CTMS solution for two oncology trials, including robust document management, audit trails, and site communication features. A no-brainer price would be around $1,500 USD per month, assuming it covers all our needs for both trials. I would stop considering it if it went over $3,000 USD per month, given my company's size and my personal income.
    View answer & full research →
Keep exploring

What would you ask next?

Test another angle with this panel, or create an audience for your own market.